Page last updated: 2024-08-05 11:25:38
thiazolopyrimidine
null
ChEBI ID: 64196
Members (3)
Member | Definition | Role |
---|---|---|
2-amino[1,3]thiazolo[4,5-d]pyrimidine-5,7-diol | 2-amino[1,3]thiazolo[4,5-d]pyrimidine-5,7-diol | |
7-[(2,6-dimethyl-4-morpholinyl)methyl]-5-thiazolo[3,2-a]pyrimidinone | 7-[(2,6-dimethyl-4-morpholinyl)methyl]-5-thiazolo[3,2-a]pyrimidinone | |
ritanserin | A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action. | ritanserin |
Research
Studies (712)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 104 (14.61) | 18.7374 |
1990's | 386 (54.21) | 18.2507 |
2000's | 138 (19.38) | 29.6817 |
2010's | 68 (9.55) | 24.3611 |
2020's | 16 (2.25) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 75 (10.05%) | 5.53% |
Reviews | 23 (3.08%) | 6.00% |
Case Studies | 5 (0.67%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 643 (86.19%) | 84.16% |